{
    "xml": "<topic id=\"PHP98908\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/spiriva-respimat\" basename=\"spiriva-respimat\" title=\"Spiriva Respimat\">\n<title>Spiriva Respimat<tm tmtype=\"reg\"/>\n</title>\n<topic id=\"PHP98935\" outputclass=\"indicationsAndDose\" rev=\"1.31\" parent=\"/clinical-medicinal-product-information/spiriva-respimat\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Maintenance treatment of chronic obstructive pulmonary disease</p>\n<p outputclass=\"therapeuticIndication\">Adjunct to inhaled corticosteroids and long-acting beta<sub>2</sub> agonists for the maintenance treatment of patients with asthma who have suffered one or more severe exacerbations in the last year</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of aerosol</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;micrograms once daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP98919\" outputclass=\"cautions\" rev=\"1.8\" parent=\"/clinical-medicinal-product-information/spiriva-respimat\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Cardiac rhythm disorders</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP99044\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.9\" parent=\"/clinical-medicinal-product-information/spiriva-respimat\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Use <i>Spiriva Respimat</i>\n<tm tmtype=\"reg\"/> only when patient unable to use <i>Spiriva Handihaler</i>\n<tm tmtype=\"reg\"/> device.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP99031\" outputclass=\"nationalFunding\" rev=\"1.8\" parent=\"/clinical-medicinal-product-information/spiriva-respimat\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (November 2007) that <i>Spiriva Respimat</i>\n<tm tmtype=\"reg\"/> is restricted for use in chronic obstructive pulmonary disease in patients who have poor manual dexterity and difficulty using the <i>Handihaler</i>\n<tm tmtype=\"reg\"/> device.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP98908",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/spiriva-respimat",
    "basename": "spiriva-respimat",
    "title": "Spiriva Respimat",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Maintenance treatment of chronic obstructive pulmonary disease",
                        "html": "Maintenance treatment of chronic obstructive pulmonary disease"
                    },
                    {
                        "textContent": "Adjunct to inhaled corticosteroids and long-acting beta2 agonists for the maintenance treatment of patients with asthma who have suffered one or more severe exacerbations in the last year",
                        "html": "Adjunct to inhaled corticosteroids and long-acting beta<sub>2</sub> agonists for the maintenance treatment of patients with asthma who have suffered one or more severe exacerbations in the last year"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of aerosol"
                    ],
                    "textContent": "By inhalation of aerosol",
                    "html": "By inhalation of aerosol"
                },
                "adult": [
                    {
                        "textContent": "5 micrograms once daily.",
                        "html": "<p>5&#8239;micrograms once daily.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Cardiac rhythm disorders",
                "html": "Cardiac rhythm disorders"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Use Spiriva Respimat only when patient unable to use Spiriva Handihaler device.",
                "html": "<p>Use <i>Spiriva Respimat</i>\n<tm tmtype=\"reg\"/> only when patient unable to use <i>Spiriva Handihaler</i>\n<tm tmtype=\"reg\"/> device.</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (November 2007) that Spiriva Respimat is restricted for use in chronic obstructive pulmonary disease in patients who have poor manual dexterity and difficulty using the Handihaler device.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (November 2007) that <i>Spiriva Respimat</i> <tm tmtype=\"reg\"/> is restricted for use in chronic obstructive pulmonary disease in patients who have poor manual dexterity and difficulty using the <i>Handihaler</i> <tm tmtype=\"reg\"/> device.</p>"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}